Wearable, smartphone-controlled, rechargeable device effective for reducing voiding frequency; is safe in overactive bladder
TUESDAY, April 2, 2024 (HealthDay News) — For patients with overactive bladder (OAB) symptoms, a wearable, smartphone-controlled, rechargeable transcutaneous tibial nerve stimulation (TTNS) device is efficacious and safe, according to a study published online March 11 in BJU International.
Limin Liao, M.D., Ph.D., from the China Rehabilitation Science Institute in Beijing, and colleagues conducted a prospective, randomized clinical trial involving eligible patients with OAB symptoms who were randomly assigned to a TTNS or sham group.
The researchers found that the mean change of voiding frequency/24 hours at four weeks was −3.5 and −0.6 in the stimulation and sham groups, respectively, in the full analysis set. The results were similar in the per-protocol set (−3.5 versus −0.4, respectively). Micturition volume/void significantly improved at four weeks in both the full analysis set and per-protocol set. The improvement in patient perception of bladder condition was almost significant in the full analysis set and was significant in the per-protocol set. The American Urological Association Symptom Index Quality of Life Score improved significantly in both groups in the full analysis and per-protocol sets; no significant differences were seen in urgency score/void, nocturia episodes/day, or overactive bladder symptom score. There were no reports of device-related serious adverse events.
“TTNS using the novel, wearable, smartphone-controlled, rechargeable, and ambulatory TTNS device is effective and safe for treating OAB,” the authors write. “This approach could be a new potential home-based treatment modality.”
Abstract/Full Text (subscription or payment may be required)
Paintball-Related Eye Injuries Declined 84.5 Percent From 2005 to 2025
Head-to-Head Comparisons Show Three Antidepressants Have Greater Long-Term Efficacy
Screening, Treating STIs During Pregnancy May Cut Preterm Birth Risk
Greater Estrogen Exposure Linked to Lower Cerebrovascular Pathology
AI Better Assesses Heart Function From MRI Than Clinicians
Oral Menopausal Hormone Therapy Linked to Venous Thromboembolic Risk
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy